← Back to all trials
Recruiting
NCT07588230
Serratus Posterior Superior Intercostal Plane Block in Minimally Invasive Cardiac Surgery
Conditions: Heart Valve Disease, Postoperative Pain
Sex: All
Ages: 18 Years – 75 Years
Healthy volunteers: No
Phase: NA
Enrollment: 90
Sponsor: Saglik Bilimleri Universitesi Gazi Yasargil Training and Research Hospital
Location: Fatma Acil Diyarbakır Outside of the US
Summary
This randomized, double-blind, placebo-controlled study aims to evaluate the effect of the serratus posterior superior intercostal plane (SPSIP) block on postoperative pain and opioid consumption in patients undergoing minimally invasive cardiac valve surgery via mini-thoracotomy.
Eligibility Criteria
Inclusion Criteria:
* Adult patients aged 18-75 years
* ASA physical status I-III
* Scheduled for elective minimally invasive cardiac valve surgery via mini-thoracotomy
* Able to understand and use the Numeric Rating Scale (NRS)
* Provided written informed consent
Exclusion Criteria:
* Age \>75 years
* Known allergy or hypersensitivity to local anesthetics (e.g., bupivacaine)
* Coagulopathy or ongoing anticoagulant therapy that cannot be discontinued
* Infection at the planned block site
* Chronic opioid use or chronic pain conditions
* Severe pulmonary disease affecting respiratory assessment
* Neurological or psychiatric disorders interfering with pain assessment
* Emergency surgery
* Pregnancy or breastfeeding
* Refusal to participate
Source: ClinicalTrials.gov (NCT07588230). StuddyBuddy aggregates publicly available trial information.